Tokyo, Aug. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062598) titled 'Multicenter Prospective Observational Study of Immune Checkpoint Inhibitor Rechallenge After Recovery From Severe ICI-Induced Liver Injury' on Aug. 18.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya University
Condition:
Condition - Patients with malignancies who experienced Grade 3 or higher immune checkpoint inhibitor-induced liver injury
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively follow patients who have recovered from Grade 3 or higher ICI-induced liver injury and undergo ICI rechallenge as part of routine clinical care...